Xiongbing Zu

4.3k total citations · 1 hit paper
166 papers, 2.8k citations indexed

About

Xiongbing Zu is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Xiongbing Zu has authored 166 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Surgery, 59 papers in Pulmonary and Respiratory Medicine and 55 papers in Molecular Biology. Recurrent topics in Xiongbing Zu's work include Bladder and Urothelial Cancer Treatments (53 papers), Urinary and Genital Oncology Studies (26 papers) and Cancer-related molecular mechanisms research (22 papers). Xiongbing Zu is often cited by papers focused on Bladder and Urothelial Cancer Treatments (53 papers), Urinary and Genital Oncology Studies (26 papers) and Cancer-related molecular mechanisms research (22 papers). Xiongbing Zu collaborates with scholars based in China, United States and Germany. Xiongbing Zu's co-authors include Jinbo Chen, Lin Qi, Jiao Hu, Huihuang Li, Longfei Liu, Minfeng Chen, Wenbiao Ren, Yu Cui, Peihua Liu and Belaydi Othmane and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Xiongbing Zu

160 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Siglec15 shapes a non-inflamed tumor microenvironment and predicts the molecular subtype in bladder cancer

2021 250 citations Jiao Hu, Anze Yu et al. profile →

Peers

Countries citing papers authored by Xiongbing Zu

Since Specialization

Citations

This map shows the geographic impact of Xiongbing Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiongbing Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiongbing Zu more than expected).

Fields of papers citing papers by Xiongbing Zu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiongbing Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiongbing Zu. The network helps show where Xiongbing Zu may publish in the future.

Co-authorship network of co-authors of Xiongbing Zu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiongbing Zu. A scholar is included among the top collaborators of Xiongbing Zu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiongbing Zu. Xiongbing Zu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A novel antioxidant and anti-inflammatory carboxymethylcellulose/chitosan hydrogel loaded with cannabidiol promotes the healing of radiation-combined wound skin injury in the 60Co γ-irradiated mice 2025 ·Phytomedicine ·Wei Zhou, (unknown), Xiongbing Zu, (unknown), Pan Shen, (unknown), Pengfei Zhang, Zhexin Ni, Ningning Wang, Dezhi Sun, Zhijie Bai, Xiang Gao, (unknown), (unknown)	3
2	Neutrophil-mediated alteration of CXCL1/IL-8/AR signaling promotes prostate cancer cell proliferation 2025 ·Experimental Cell Research ·(unknown), (unknown), (unknown), Zhen Li, (unknown), (unknown), Jiao Hu, Yuanwei Li, Xiongbing Zu, (unknown)	1
3	Modified Tubeless Ureterocutaneostomy in High-Risk Patients After Radical Cystectomy and its Long-Term Clinical Outcomes 2023 ·Technology in Cancer Research & Treatment ·Mingyong Li, (unknown), Xiongbing Zu, Jinbo Chen, Minfeng Chen	0
4	The androgen receptor in bladder cancer 2023 ·Nature Reviews Urology ·Jinbo Chen, Chi‐Ping Huang, Chao Quan, Xiongbing Zu, Zhenyu Ou, Yu‐Chieh Tsai, Edward M. Messing, Shuyuan Yeh, Chawnshang Chang	29
5	Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8⁺ T cell infiltration and functional transition 2023 ·Journal for ImmunoTherapy of Cancer ·Anze Yu, Jiao Hu, Liangmin Fu, (unknown), (unknown), Mingxiao Zhang, Yinghan Wang, Guannan Shu, (unknown), Huihuang Li, Xu Chen, Taowei Yang, Jinhuan Wei, Zhenhua Chen, Xiongbing Zu, Junhang Luo	14
6	Cuproptosis-related modification patterns depict the tumor microenvironment, precision immunotherapy, and prognosis of kidney renal clear cell carcinoma 2022 ·Frontiers in Immunology ·Zhiyong Cai, (unknown), (unknown), Jiao Hu, (unknown), Xiongbing Zu, Zhenghao Li, Huihuang Li	24
7	Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma 2021 ·Translational Andrology and Urology ·Yangle Li, Xiongbing Zu, Xiheng Hu, Zhao Cheng, Miao Mo, (unknown)	4
8	Circular RNA circKIF4A Sponges miR-375/1231 to Promote Bladder Cancer Progression by Upregulating NOTCH2 Expression 2020 ·Frontiers in Pharmacology ·(unknown), (unknown), Kun Xiong, Qianjin Liao, Ye Xu, Pei Yang, Xiongbing Zu	29
9	Circular RNA DOCK1 promotes bladder carcinoma progression via modulating circDOCK1/hsa‐miR‐132‐3p/Sox5 signalling pathway 2019 ·Cell Proliferation ·Peihua Liu, Xiaozhou Li, Xi Guo, Jinbo Chen, Chao Li, Minfeng Chen, Longfei Liu, Xiangyang Zhang, Xiongbing Zu	67
10	LncRNA-MALAT1 mediates cisplatin resistance via miR-101-3p/VEGF-C pathway in bladder cancer 2019 ·Acta Biochimica et Biophysica Sinica ·Peihua Liu, Xiaozhou Li, Yu Cui, Jinbo Chen, Chao Li, Qiaqia Li, Huihuang Li, (unknown), Xiongbing Zu	51
11	Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling 2019 ·Oncogene ·Jinbo Chen, Fu-Ju Chou, Shuyuan Yeh, Zhenyu Ou, Chih‐Rong Shyr, Chi‐Ping Huang, Zhendong Xiang, Yin Sun, Edward M. Messing, Xiongbing Zu, Chawnshang Chang	31
12	Delayed versus standard ligature of the dorsal venous complex during laparoscopic radical prostatectomy: A systematic review and meta-analysis of comparative studies 2019 ·International Journal of Surgery ·Huihuang Li, Jinbo Chen, Yu Cui, Peihua Liu, Zhenglin Yi, Xiongbing Zu	4
13	CLASP2 is involved in the EMT and early progression after transurethral resection of the bladder tumor 2017 ·BMC Cancer ·(unknown), Lin Qi, Sulai Liu, Wentao Liu, Zhenyu Ou, Minfeng Chen, Longfei Liu, Xiongbing Zu, Jun Wang, Yuan Li	17
14	Retroperitoneoscopic Partial Nephrectomy for Moderately Complex Ventral Hilar Tumors: Surgical Technique and Trifecta Outcomes from a Single Institution in China 2016 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Longfei Liu, Lin Qi, Yangle Li, Minfeng Chen, Chao Li, Cheng Xu, Peihua Liu, Xiongbing Zu	6
15	Sexual Function after Partial Penectomy: A Prospectively Study From China 2016 ·Scientific Reports ·Yu Cui, Hequn Chen, Longfei Liu, Minfeng Chen, (unknown), Feng Zeng, Jinbo Chen, Lin Qi, Xiongbing Zu	30
16	Overexpression of Wip1 Is Associated with Biologic Behavior in Human Clear Cell Renal Cell Carcinoma 2014 ·PLoS ONE ·Sulai Liu, Lin Qi, (unknown), Xin-xing Wan, Shusuan Jiang, Yuan Li, Yu Xie, Longfei Liu, (unknown), Zhizhong Liu, Xiongbing Zu	17
17	Development and Validation of an Animal Model of Prostate Inflammation-Induced Chronic Pelvic Pain: Evaluating from Inflammation of the Prostate to Pain Behavioral Modifications 2014 ·PLoS ONE ·Feng Zeng, Hequn Chen, Jinrui Yang, Long Wang, Yu Cui, Xiao Guan, Zhao Wang, (unknown), Xiongbing Zu, Lin Qi, Xiangyang Zhang, Zhengyan Tang, Longfei Liu	24
18	Preliminary Experience and Learning Curve for Laparoendoscopic Single-Site Retroperitoneal Pyeloplasty 2013 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Zhenyu Ou, Lin Qi, Jinrui Yang, Xiang Chen, Zhenzhen Cao, Xiongbing Zu, Longfei Liu, Long Wang	3
19	5-Aza-2′-Deoxycytidine Enhances Maspin Expression and Inhibits Proliferation, Migration, and Invasion of the Bladder Cancer T24 Cell Line 2013 ·Cancer Biotherapy and Radiopharmaceuticals ·Huihui Zhang, Qi Fan, (unknown), Xiongbing Zu, Minfeng Chen, Zhuo Li, (unknown)	20
20	RNA Interference-Mediated Vascular Endothelial Growth Factor-C Reduction Suppresses Malignant Progression and Enhances Mitomycin C Sensitivity of Bladder Cancer T24 Cells 2011 ·Cancer Biotherapy and Radiopharmaceuticals ·Huihui Zhang, Qi Fan, (unknown), (unknown), Mi Zhou, Wei He, Minfeng Chen, (unknown), Xiongbing Zu, (unknown)	16

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact